Neochem Bio Solutions Reports Strong H1 FY27 Results and Leadership Appointments
Neochem Bio Solutions Ltd · Outcome · 28 Oct 2026, 12:23 am
Neochem Bio Solutions Reports Strong H1 FY27 Results and Leadership Appointments For the half-year ended 30th Sep'26, Neochem Bio Solutions posted revenue from operations of ₹6,892.43 Lakhs, up 50.39% YoY from ₹4,583.16 Lakhs. Net profit rose 43.09% YoY to ₹784.69 Lakhs versus ₹548.38 Lakhs, with basic EPS reaching ₹4.58. Profit before tax stood at ₹1,045.59 Lakhs against ₹732.83 Lakhs in H1 FY26. Additionally, the board approved the appointment of CA Harshit Shah as Chief Financial Officer and Mr. Vikram Nair as Chief Commercial Officer, effective 27th Oct'26, while former CFO Mr. Pradip Solanki transitioned to Senior Management.
Original exchange filing (PDF)
More announcements from Neochem Bio Solutions Ltd
- Neochem Bio Solutions Limited has informed the Exchange about Transcript · 03 Nov 2026
- Neochem Bio Solutions Limited has informed the Exchange about Link of Recording · 30 Oct 2026
- Neochem Bio Solutions Limited has informed the Exchange about Investor Presentation · 29 Oct 2026
- Neochem Bio Solutions Limited has informed the Exchange about Schedule of meet · 27 Oct 2026
- NEOCHEM BIO SOLUTIONS LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 27 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 27 Oct 2026
- Neochem Bio Solutions has submitted Statement of Investor Grievances under Reg. 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2026. · 20 Oct 2026
- Neochem Bio Solutions Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Quarter and half year ended on 30th September, 2026 · 20 Oct 2026
